quindoxin has been researched along with EHS Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguirre, G; Arredondo, C; Basombrío, MA; Boiani, M; Cerecetto, H; Fernández, M; González, M; León, E; Pacheco, JP; Pintos, C; Raymondo, S | 1 |
1 other study(ies) available for quindoxin and EHS Tumor
Article | Year |
---|---|
Furoxan derivatives as cytotoxic agents: preliminary in vivo antitumoral activity studies.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Oxadiazoles; Quinoxalines; Sarcoma, Experimental | 2006 |